The number of people with susceptibility test result for rifampicin in Mexico
Mexico: The number of people with susceptibility test result for rifampicin was 4,205 in 2021. ◆ Volatile
Latest (2021)
4,205
Change on year
up 84.8%
World rank
34th
of 155 countries
All-time high
4,205
in 2021
All-time low
53
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Mexico, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Mexico stood at 4,205. That is the highest value across all 5 years on record.
That represents a change of up 84.8% on the previous year and up 7,834.0% over five years.
Mexico ranks 34th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Mexico, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 53 | — |
| 2018 | 80 | +50.9% |
| 2019 | 418 | +422.5% |
| 2020 | 2,275 | +444.3% |
| 2021 | 4,205 | +84.8% |
Mexico compared with similar countries
- Mexico's 4,205 is above the median for upper middle income countries, which is 880, 4.8× the median. (46 countries reporting)
- Mexico's 4,205 is above the median for Latin America & Caribbean, which is 406.5, 10.3× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 183.67 | 53 | 418 | 3 |
| 2020s | 3,240 | 2,275 | 4,205 | 2 |
Countries ranked near Mexico
More health data for Mexico
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,312 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,760 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.9607 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0377 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.9678 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Mexico?
- The number of people with susceptibility test result for rifampicin in Mexico was 4,205 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Mexico?
- The highest recorded value was 4,205 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Mexico?
- The lowest recorded value was 53 in 2017.
- How does Mexico rank for the number of people with susceptibility test result for rifampicin?
- Mexico ranks 34th out of 155 countries with data for 2021.
- Where does this Mexico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).